Form 4: XOMA CFO Granted Significant Equity Awards

XOMA Royalty Corp's Chief Financial Officer, Jeffrey Trigilio, was granted 90,000 restricted stock units and 138,462 performance stock units.

Summary

• Jeffrey Trigilio, Chief Financial Officer of XOMA Royalty Corp, was granted 90,000 shares of common stock in the form of Restricted Stock Units (RSUs) on March 11, 2026.
• These RSUs will vest as to 25% on each of the first four anniversaries of January 12, 2026, contingent on continued service to the Issuer.
• Additionally, Mr. Trigilio was granted 138,462 Performance Stock Units (PSUs) on March 11, 2026.
• Each PSU represents a contingent right to receive one share of common stock, vesting upon the common stock achieving a specified price per share, also subject to continued service through each vesting date.

Sentiment

Score: 7

Explanation: StockSavvy.ai views this as a moderately positive signal, as it indicates management's long-term commitment and aligns their incentives with shareholder value through equity-based compensation.

Positives

• The grant of equity awards aligns the Chief Financial Officer's long-term interests with those of shareholders, incentivizing performance and retention.
• Equity-based compensation is a common practice to motivate executives to achieve company growth and stock price appreciation.

Negatives

• Potential future dilution of existing shares upon the vesting and conversion of the granted Restricted Stock Units and Performance Stock Units into common stock.

Risks

• Vesting of the 90,000 Restricted Stock Units is contingent on Jeffrey Trigilio's continued service to XOMA Royalty Corp through each vesting date.
• Vesting of the 138,462 Performance Stock Units is contingent on both the common stock achieving a specified price per share and Mr. Trigilio's continued service to the Issuer through each vesting date.
• Future dilution of existing shareholder equity will occur when the granted RSUs and PSUs convert into common stock upon vesting.

Future Outlook

The grant of Performance Stock Units, which vest upon the common stock achieving a specified price per share, indicates a forward-looking incentive tied to the company's future share price performance.

Industry Context

StockSavvy.ai notes that equity grants, including restricted stock units and performance stock units, are a common practice in the biotechnology and royalty industries to incentivize executive performance and align management's interests with long-term shareholder value.

Comparison to Industry Standards

• Equity-based compensation, including restricted stock units and performance stock units, is a standard practice in the biotechnology and pharmaceutical royalty industries for executive incentive and retention.
• No specific comparable companies or projects are detailed in this filing to allow for a direct quantitative comparison of the grant size.

Stakeholder Impact

• Shareholders: Potential for future dilution upon vesting of equity awards, but also benefit from increased alignment of management's interests with long-term shareholder value.
• Jeffrey Trigilio (CFO): Receives significant equity incentives tied to the company's performance and his continued service.

Next Steps

• Vesting of Restricted Stock Units will occur annually over the next four years, starting from January 12, 2026, subject to continued service.
• Vesting of Performance Stock Units will occur upon the common stock achieving a specified price per share, subject to continued service.

Key Dates

Recommendation

The equity grants to the CFO align management's long-term interests with shareholder value, which is generally a positive for corporate governance. However, this filing alone does not provide sufficient information to change a broader investment thesis, thus a 'hold' recommendation is appropriate.

Keywords

XOMA Royalty Corp, XOMA, Form 4, SEC filing, insider transaction, equity grant, restricted stock units, performance stock units, CFO, Jeffrey Trigilio, executive compensation